REFERENCES
- Koizumi , M. , Koga , R. , Hotoda , H. , Ohmine , T. , Furukawa , H. , Agatsuma , T. , Nishigaki , T. , Abe , K. , Kosaka , T. , Tsutsumi , S. , Sone , J. , Kaneko , M. , Rimura , S. and Shimada , K. 1997 . Biologically active oligodeoxyribonucleotides – IX. Synthesis and anti-HIV-1 activity of hexadeoxyribonucleotides, TGGGAG, bearing 3′- and 5′-end-modification . Bioorg. Med. Chem. , 12 : 2235 – 2243 .
- Hotoda , H. , Koizumi , M. , Koga , R. , Kaneko , M. , Momota , K. , Ohmine , T. , Furukawa , H. , Agatsuma , T. , Nishigaki , T. , Sone , J. , Tsutsumi , S. , Kosaka , T. , Abe , K. , Kimura , S. and Shimada , K. 1998 . Biologically active oligodeoxyribonucleotides. 5. 5′-End-substituted d(TGGGAG) possesses anti-human immunodeficiency virus type 1 activity by forming a G-quadruplex structure . J. Med. Chem. , 41 : 3655 – 3663 .
- Koizumi , M. , Kaneko , M. , Ohmine , T. , Furukawa , H. and Nishigaki , T. Modified antisense oligodeoxyribonucleotides having TGGG sequence for treating AIDS . Patent JP98/04625; PCT/WO99/19474 . 1999 .
- Keniry , M. A. 2001 . Quadruplex structures in nucleic acids . Biopolymers , 56 : 123 – 146 .
- Petraccone , L. , Barone , G. and Giancola , C. 2005 . Quadruplex-forming oligonucleotides as tools in anticancer therapy and aptamer design: energetic aspects . Curr. Med. Chem-Anticancer Agents , 5 : 463 – 475 .
- Adinolfi , M. , De Napoli , L. , Di Fabio , G. , Iadonisi , A. and Montesarchio , D. 2004 . Modulating the activity of oligonucleotides: solid phase synthesis of sucrose-oligonucleotide hybrids . Org. Biomol. Chem. , 2 : 1879 – 1886 . and references cited therein
- Oligonucleotides c e g could have alternatively synthesized using commercially available universal solid supports and 2′-deoxyribonucleoside 5′-phosphoramidites, in connection with sugar phosphoramidite building block 5. This strategy was here not adopted on the basis of the overall higher costs and lower expected yields associated with the usage of nucleoside 5′-phosphoramidites